Gary Nabors – Biography
Last update: December 9, 2025Executive profile
Gary was Executive Vice President & Chief Development OfficerExecutive Vice President & Chief Development Officer at Integrated BioTherapeutics, and President at DynPort Vaccine. Gary Nabors joined Appili Therapeutics in 2023.
Gary Nabors is currentlyChief Development Officer at Appili Therapeutics - View - Appili Therapeutics org chart
Create your alert
to follow the career of Gary Nabors.
Education
Gary Nabors has a Bachelor in Biology from Wake Forest University and a PhD in Immunology from University of Georgia.
They have also studied at Wake Forest University :
Find more alumni from Wake Forest University
They have also studied at University of Georgia :
Find more alumni from University of Georgia
More about Gary Nabors
Selected links
Do you need to know more about Gary Nabors? More results.
Participate
Social media
- Gary Nabors on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Gary Nabors
The colleagues of Gary Nabors
Company Colleagues
- At Appili Therapeutics, Gary Nabors has 13 colleagues including Don Cilla (CEO & Director), Juergen Froehlich (Director)…
Industry Colleagues
- In the Biotechnology industry, Gary Nabors has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Gary Nabors.
Get in Touch
Here are a few tips for establishing great contacts.
